Histological variants of urothelial carcinoma: Diagnostic, therapeutic and prognostic implications

Modern Pathology

Volumn 22, Issue SUPPL. 2, 2009, Pages

  Amin, Mahul B ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Clear cell features; Large cell neuroendocrine carcinoma; Lipoid rich; Lymphoepithelioma like; Microcystic carcinoma; Nested; Osteoclast rich; Plasmacytoid rhabdoid; Sarcomatoid carcinoma; Small cell; Small tubules; Urothelial carcinoma; Variants

Indexed keywords

ACTIN; CALDESMON; CHROMOGRANIN; CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7; DESMIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITHELIAL MEMBRANE ANTIGEN; GLYCOGEN; LIPID; MONOCLONAL ANTIBODY KI 67; PROSTATE SPECIFIC ANTIGEN; PROTEIN P53; PROTEIN P63; PROTEIN S 100; STEM CELL FACTOR RECEPTOR; THROMBOMODULIN; UROPLAKIN;

BENIGN TUMOR; BLADDER CANCER; CANCER CLASSIFICATION; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER INVASION; CANCER SURVIVAL; CARCINOID; CARCINOMA IN SITU; CELL TYPE; CHORIOCARCINOMA; CLINICAL PRACTICE; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; GIANT CELL TUMOR; HISTOCHEMISTRY; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; KIDNEY PELVIS TUMOR; LARGE CELL CARCINOMA; LEIOMYOSARCOMA; LYMPHOEPITHELIOMA LIKE CARCINOMA; MELANOMA; MICROCYSTIC CARCINOMA; MICROPAPILLARY UROTHELIAL CARCINOMA; MORPHOLOGY; NEUROENDOCRINE TUMOR; OSTEOCLAST; PARAGANGLIOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RHABDOID TUMOR; SARCOMATOID CARCINOMA; SMALL CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT TUMOR; WORLD HEALTH ORGANIZATION;

HUMANS; PROGNOSIS; UROLOGIC NEOPLASMS;

EID: 67149084303     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2009.26     Document Type: Review

References (135)

1. Amin MB, Murphy WM, Reuter VE, et al. A symposium on controversies in the pathology of transitional cell carcinomas of the urinary bladder. Part I. Anat Pathol 1996;1:1-39.
2. Eble JN, Young RH. Carcinoma of the urinary bladder: a review of its diverse morphology. Semin Diagn Pathol 1997;14:98-108.
3. Nigwekar P, Amin MB. The many faces of urothelial carcinoma: an update with an emphasis on recently described variants. Adv Anat Pathol 2008;15:218-233.
4. Young RH, Eble JN. Unusual forms of carcinoma of the urinary bladder. Hum Pathol 1991;22:948-965.
5. Zhai QJ, Black J, Ayala AG, et al. Histologic variants of infiltrating urothelial carcinoma. Arch Pathol Lab Med 2007;131:1244-1256.
6. Eble JN, Epstein JI, Sesterhenn IA. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. In: IARC (ed). Vol.: Lyon, France, 2004.
7. Perez-Montiel D, Hes O, Michal M, et al. Micropapil-lary urothelial carcinoma of the upper urinary tract: clinicopathologic study of five cases. Am J Clin Pathol 2006;126:86-92.
8. Black PC, Brown GA, Dinney CP. The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol 2009;27:3-7.
9. Kipp BR, Tyner HL, Campion MB, et al. Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer. Am J Clin Pathol 2008;130: 552-559.
10. Budia Alba A, Queipo Zaragoza JA, Perez Ebri ML, et al. Comparative study of pure epidermoid carcinoma of the bladder and transitional cell carcinoma with squamous or mixed differentiated foci. Actas Urol Esp 1999;23:111-118.
11. Hong JY, Choi MK, Uhm JE, et al. Palliative chemotherapy for non-transitional cell carcinomas of the urothelial tract. Med Oncol 2008; e-pub ahead of print.
12. Lopez-Beltran A, Martin J, Garcia J, et al. Squamous and glandular differentiation in urothelial bladder carcinomas. Histopathology, histochemistry and immunohistochemical expression of carcinoembryonic antigen. Histol Histopathol 1988;3:63-68.
13. Ro J, Lapham R, M A. Deceptively bland transitional cell carcinoma of the urinary bladder-further characterization of subtle and diagnostically tracherous patterns of invasion in urothelial neoplasia. Adv Anat Pathol 1997;4:244-251.
14. Young RH, Oliva E. Transitional cell carcinomas of the urinary bladder that may be underdiagnosed. A report of four invasive cases exemplifying the homology between neoplastic and non-neoplastic transitional cell lesions. Am J Surg Pathol 1996;20: 1448-1454.
15. Baker PM, Young RH. Radiation-induced pseudocarcinomatous proliferations of the urinary bladder: a report of 4 cases. Hum Pathol 2000;31:678-683.
16. Talbert ML, Young RH. Carcinomas of the urinary bladder with deceptively benign-appearing foci. A report of three cases. Am J Surg Pathol 1989;13: 374-381.
17. Dhall D, Al-Ahmadie H, Olgac S. Nested variant of urothelial carcinoma. Arch Pathol Lab Med 2007;131: 1725-1727.
18. Drew PA, Furman J, Civantos F, et al. The nested variant of transitional cell carcinoma: an aggressive neoplasm with innocuous histology. Mod Pathol 1996;9:989-994.
19. Holmang S, Johansson SL. The nested variant of transitional cell carcinoma - a rare neoplasm with poor prognosis. Scand J Urol Nephrol 2001;35:102-105.
20. Lin O, Cardillo M, Dalbagni G, et al. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases. Mod Pathol 2003; 16:1289-1298.
21. Murphy WM, Deana DG. The nested variant of transitional cell carcinoma: a neoplasm resembling proliferation of Brunn's nests. Mod Pathol 1992;5: 240-243.
22. Nese N, Kandiloglu AR, Atesci YZ. Nested variant of transitional cell carcinoma with osseous metaplasia of the urinary bladder: a case report and review of published reports. Int J Urol 2007;14:365-367.
23. Oliva E, Young RH. Nephrogenic adenoma of the urinary tract: a review of the microscopic appearance of 80 cases with emphasis on unusual features. Mod Pathol 1995;8:722-730.
24. McKenney JK, Amin MB. The role of immunohistochemistry in the diagnosis of urinary bladder neoplasms. Semin Diagn Pathol 2005;22:69-87.
25. Volmar KE, Chan TY, De Marzo AM, et al. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma. Am J Surg Pathol 2003;27:1243-1252.
26. Huang Q, Chu PG, Lau SK, et al. Urothelial carcinoma of the urinary bladder with a component of acinar/ tubular type differentiation simulating prostatic ade-nocarcinoma. Hum Pathol 2004;35:769-773.
27. Leroy X, Leteurtre E, De La Taille A, et al. Microcystic transitional cell carcinoma: a report of 2 cases arising in the renal pelvis. Arch Pathol Lab Med 2002;126: 859-861.
28. Young RH, Zukerberg LR. Microcystic transitional cell carcinomas of the urinary bladder. A report of four cases. Am J Clin Pathol 1991;96:635-639.
29. Sari A, Uyaroglu MA, Ermete M, et al. Microcystic urothelial carcinoma of the urinary bladder metastatic to the penis. Pathol Oncol Res 2007;13:170-173.
30. Amin MB, Gomez JA, Young RH. Urothelial transitional cell carcinoma with endophytic growth patterns: a discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases. Am J Surg Pathol 1997;21:1057-1068.
31. Jimenez RE, Keane TE, Hardy HT, et al. pT1 urothelial carcinoma of the bladder: criteria for diagnosis, pitfalls, and clinical implications. Adv Anat Pathol 2000;7:13-25.
32. Jones TD, Zhang S, Lopez-Beltran A, et al. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis. Am J Surg Pathol 2007;31: 1861-1867.
33. Kamat AM, Dinney CP, Gee JR, et al. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer 2007;110:62-67.
34. Johansson SL, Borghede G, Holmang S. Micropapillary bladder carcinoma: a clinicopathological study of 20 cases. J Urol 1999;161:1798-1802.
35. Charfi S, Moussa A, Njim L, et al. Micropapillary bladder carcinoma. Prog Urol 2006;16:607-609.
36. Holmang S, Thomsen J, Johansson SL. Micropapillary carcinoma of the renal pelvis and ureter. J Urol 2006;175:463-466; discussion 466-467.
37. Alvarado-Cabrero I, Sierra-Santiesteban FI, Mantilla-Morales A, et al. Micropapillary carcinoma of the urothelial tract. A clinicopathologic study of 38 cases. Ann Diagn Pathol 2005;9:1-5.
38. Dhouib RS, Abbes I, Mrad K, et al. Micro-papillary transitional cell carcinoma of the urinary bladder: report of two cases. Pathologica 2005; 97:338-340.
39. Munakata S, Tahara H, Kojima K, et al. Micropapil-lary urothelial carcinoma of the renal pelvis: report of a case and review of the literature. Med Sci Monit 2007;13:CS47-CS52.
40. Amin MB, Ro JY, el-Sharkawy T, et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 1994;18: 1224-1232.
41. Ylagan LR, Humphrey PA. Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens. Acta Cytol 2001;45:599-604.
42. Samaratunga H, Khoo K. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Histopathology 2004;45:55-64.
43. Regalado JJ. Mixed micropapillary and trophoblastic carcinoma of bladder: report of a first case with new immunohistochemical evidence of urothelial origin. Hum Pathol 2004;35:382-384.
44. Parker DC, Folpe AL, Bell J, et al. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas. Am J Surg Pathol 20031;27:1-10.
45. Kamat AM, Gee JR, Dinney CP, et al. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol 2006;175 (3 Part 1):881-885.
46. Holmang S, Borghede G, Johansson SL. Bladder carcinoma with lymphoepithelioma-like differentiation: a report of 9 cases. J Urol 1998;159:779-782.
47. Gulley ML, Amin MB, Nicholls JM, et al. Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithe-lioma-like carcinoma of the urinary bladder. Hum Pathol 1995;26:1207-1214.
48. Dinney CP, Ro JY, Babaian RJ, et al. Lymphoepithelioma of the bladder: a clinicopathological study of 3 cases. J Urol 1993;149:840-841.
49. Amin MB, Ro JY, Lee KM, et al. Lymphoepithelioma-like carcinoma of the urinary bladder. Am J Surg Pathol 1994;18:466-473.
50. Lopez-Beltran A, Luque RJ, Vicioso L, et al. Lymphoepithelioma- like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases. Virchows Arch 2001;438:552-557.
51. Tamas EF, Nielsen ME, Schoenberg MP, et al. Lymphoepithelioma-like carcinoma of the urinary tract: a clinicopathological study of 30 pure and mixed cases. Mod Pathol 2007;20:828-834.
52. Lopez-Beltran A, Pacelli A, Rothenberg HJ, et al. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. J Urol 1998;159:1497-1503.
53. Wright JL, Black PC, Brown GA, et al. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. J Urol 2007;178:2302-2306; discussion 2307.
54. Sung MT, Wang M, MacLennan GT, et al. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol 2007;211: 420-430.
55. Jones EC, Young RH. Myxoid and sclerosing sarcomatoid transitional cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 25 cases. Mod Pathol 1997;10:908-916.
56. Acikalin MF, Kabukcuoglu S, Can C. Sarcomatoid carcinoma of the renal pelvis with giant cell tumorlike features: case report with immunohistochemical findings. Int J Urol 2005;12:199-203.
57. Young RH, Wick MR, Mills SE. Sarcomatoid carcinoma of the urinary bladder. A clinicopathologic analysis of 12 cases and review of the literature. Am J Clin Pathol 1988;90:653-661.
58. Torenbeek R, Blomjous CE, de Bruin PC, et al. Sarcomatoid carcinoma of the urinary bladder. Clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findings. Am J Surg Pathol 1994;18:241-249.
59. Ikegami H, Iwasaki H, Ohjimi Y, et al. Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients. Hum Pathol 2000;31:332-340.
60. Reuter VE. Sarcomatoid lesions of the urogenital tract. Semin Diagn Pathol 1993;10:188-201.
61. Young RH, Wick MR. Transitional cell carcinoma of the urinary bladder with pseudosarcomatous stroma. Am J Clin Pathol 1988;90:216-219.
62. Wick MR, Swanson PE. Carcinosarcomas: current perspectives and an historical review of nosological concepts. Semin Diagn Pathol 1993;10:118-127.
63. Armstrong AB, Wang M, Eble JN, et al. TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol 2009;22: 113-118.
64. Shah SK, Lui PD, Baldwin DD, et al. Urothelial carcinoma after external beam radiation therapy for prostate cancer. J Urol 2006;175:2063-2066.
65. Harik LR, Merino C, Coindre JM, et al. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol 2006;30:787-794.
66. Westfall DE, Folpe AL, Paner GP, et al. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol 2009;33:99-105.
67. Pan CX, Yang XJ, Lopez-Beltran A, et al. c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Mod Pathol 2005;18:320-323.
68. Agoff SN, Lamps LW, Philip AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 2000;13: 238-242.
69. Bex A, Nieuwenhuijzen JA, Kerst M, et al. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology 2005;65:295-299.
70. Sved P, Gomez P, Manoharan M, et al. Small cell carcinoma of the bladder. BJU Int 2004;94:12-17.
71. Abrahams NA, Moran C, Reyes AO, et al. Small cell carcinoma of the bladder: a contemporary clinico-pathological study of 51 cases. Histopathology 2005; 46:57-63.
72. Wang W, Epstein JI. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol 2008;32:65-71.
73. Choong NW, Quevedo JF, Kaur JS. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Cancer 2005;103:1172-1178.
74. Mukesh M, Cook N, Hollingdale AE, et al. Small cell carcinoma of the urinary bladder: a 15-year retrospective review of treatment and survival in the Anglian Cancer Network. BJU Int 2008;103:747-752.
75. Cheng L, Pan CX, Yang XJ, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 2004;101:957-962.
76. Mills SE, Wolfe III JT, Weiss MA, et al. Small cell undifferentiated carcinoma of the urinary bladder. A light-microscopic, immunocytochemical, and ultrastructural study of 12 cases. Am J Surg Pathol 1987; 11:606-617.
77. Mangar SA, Logue JP, Shanks JH, et al. Small-cell carcinoma of the urinary bladder: 10-year experience. Clin Oncol (R Coll Radiol) 2004;16:523-527.
78. Weiss MA. Small-cell carcinoma of the urinary tract. Important prognostic and therapeutic implications. Arch Pathol Lab Med 1993;117:237-238.
79. Wang X, Zhang S, MacLennan GT, et al. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin Cancer Res 2007;13:953-957.
80. Terracciano L, Richter J, Tornillo L, et al. Chromosomal imbalances in small cell carcinomas of the urinary bladder. J Pathol 1999;189:230-235.
81. Abbosh PH, Wang M, Eble JN, et al. Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. Mod Pathol 2008;21:355-362.
82. Paner GP, McKenney JK, Epstein JI, et al. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Am J Surg Pathol 2008;32:1022-1028.
83. Bex A, de Vries R, Pos F, et al. Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder. World J Urol 2009;27:101-106.
84. Sweeney P, Millikan R, Donat M, et al. Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? J Urol 2003;169: 2113-2117.
85. Vakar-Lopez F, True LD. How wide is the spectrum of neuroendocrine carcinoma of the urinary bladder? Am J Clin Pathol 2007;128:723-725.
86. Alijo Serrano F, Sanchez-Mora N, Angel Arranz J, et al. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution. Am J Clin Pathol 2007;128:733-739.
87. Evans AJ, Al-Maghrabi J, Tsihlias J, et al. Primary large cell neuroendocrine carcinoma of the urinary bladder. Arch Pathol Lab Med 2002;126:1229-1232.
88. Hailemariam S, Gaspert A, Komminoth P, et al. Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder. Mod Pathol 1998;11:1016-1020.
89. Martignoni G, Eble JN. Carcinoid tumors of the urinary bladder. Immunohistochemical study of 2 cases and review of the literature. Arch Pathol Lab Med 2003;127:e22-e24.
90. McCabe JE, Das S, Dowling P, et al. Oncocytic carcinoid tumour of the bladder. J Clin Pathol 2005; 58:446-447.
91. Murali R, Kneale K, Lalak N, et al. Carcinoid tumors of the urinary tract and prostate. Arch Pathol Lab Med 2006;130:1693-1706.
92. Dirnhofer S, Koessler P, Ensinger C, et al. Production of trophoblastic hormones by transitional cell carcinoma of the bladder: association to tumor stage and grade. Hum Pathol 1998;29:377-382.
93. Iles RK, Chard T. Human chorionic gonadotropin expression by bladder cancers: biology and clinical potential. J Urol 1991;145:453-458.
94. Iles RK, Jenkins BJ, Oliver RT, et al. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer. Br J Urol 1989;64:241-244.
95. Martin JE, Jenkins BJ, Zuk RJ, et al. Human chorionic gonadotrophin expression and histological findings as predictors of response to radiotherapy in carcinoma of the bladder. Virchows Arch A Pathol Anat Histopathol 1989;414:273-277.
96. Sievert K, Weber EA, Herwig R, et al. Pure primary choriocarcinoma of the urinary bladder with long-term survival. Urology 2000;56:856.
97. Rodriguez E, Mathew S, Reuter V, et al. Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res 1992;52: 2285-2291.
98. Shimada K, Nakamura M, Ishida E, et al. Urothelial carcinoma with plasmacytoid variants producing both human chorionic gonadotropin and carbohydrate antigen 19-9. Urology 2006;68:891.e7-891.e10.
99. Coyne JD, Sim E. Urothelial neoplasia with plasma-cytoid morphology. Histopathology 2006;48:200-201.
100. Fritsche HM, Burger M, Denzinger S, et al. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases. J Urol 2008;180:1923-1927.
101. Gaafar A, Garmendia M, de Miguel E, et al. [Plasmacytoid urothelial carcinoma of the urinary bladder. A study of 7 cases]. Actas Urol Esp 2008;32:806-810.
102. Kohno T, Kitamura M, Akai H, et al. Plasmacytoid urothelial carcinoma of the bladder. Int J Urol 2006; 13:485-486.
103. Mai KT, Park PC, Yazdi HM, et al. Plasmacytoid urothelial carcinoma of the urinary bladder report of seven new cases. Eur Urol 2006;50:1111-1114.
104. Nigwekar P, Tamboli P, Amin MB, et al. Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases. Am J Surg Pathol 2009;33:417-424.
105. Ro JY, Shen SS, Lee HI, et al. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases. Am J Surg Pathol 2008;32:752-757.
106. Sahin AA, Myhre M, Ro JY, et al. Plasmacytoid transitional cell carcinoma. Report of a case with initial presentation mimicking multiple myeloma. Acta Cytol 1991;35:277-280.
107. Sato K, Ueda Y, Kawamura K, et al. Plasmacytoid urothelial carcinoma of the urinary bladder: a case report and immunohistochemical study. Pathol Res Pract 2008;205:189-194.
108. Soylu A, Aydin NE, Yilmaz U, et al. Urothelial carcinoma featuring lipid cell and plasmacytoid morphology with poor prognostic outcome. Urology 2005;65:797.
109. Zhang XM, Elhosseiny A, Melamed MR. Plasmacytoid urothelial carcinoma of the bladder. A case report and the first description of urinary cytology. Acta Cytol 2002;46:412-416.
110. Baldwin L, Lee AH, Al-Talib RK, et al. Transitional cell carcinoma of the bladder mimicking lobular carcinoma of the breast: a discohesive variant of urothelial carcinoma. Histopathology 2005;46:50-56.
111. Kumar S, Kumar D, Cowan DF. Transitional cell carcinoma with rhabdoid features. Am J Surg Pathol 1992;16:515-521.
112. Parwani AV, Herawi M, Volmar K, et al. Urothelial carcinoma with rhabdoid features: report of 6 cases. Hum Pathol 2006;37:168-172.
113. Hoot AC, Russo P, Judkins AR, et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol 2004;28:1485-1491.
114. Gilcrease MZ, Delgado R, Vuitch F, et al. Clear cell adenocarcinoma and nephrogenic adenoma of the urethra and urinary bladder: a histopathologic and immunohistochemical comparison. Hum Pathol 1998;29:1451-1456.
115. Kotliar SN, Wood CG, Schaeffer AJ, et al. Transitional cell carcinoma exhibiting clear cell features. A differential diagnosis for clear cell adenocarcinoma of the urinary tract. Arch Pathol Lab Med 1995; 119:79-81.
116. Oliva E, Amin MB, Jimenez R, et al. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Am J Surg Pathol 2002;26:190-197.
117. Sun K, Huan Y, Unger PD. Clear cell adenocarcinoma of urinary bladder and urethra: another urinary tract lesion immunoreactive for P504S. Arch Pathol Lab Med 2008;132:1417-1422.
118. Sung MT, Zhang S, MacLennan GT, et al. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Clin Cancer Res 2008;14:1947-1955.
119. Sim SJ, Ro JY, Ordonez NG, et al. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study. Mod Pathol 1999;12: 351-355.
120. Gupta R, Balzer B, Picken M, et al. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Am J Surg Pathol 2009;33:241-247.
121. Di Como CJ, Urist MJ, Babayan I, et al. p63 Expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494-501.
122. Lane Z, Hansel DE, Epstein JI. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Am J Surg Pathol 2008;32:1322-1326.
123. Leroy X, Gonzalez S, Zini L, et al. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases. Am J Surg Pathol 2007;31:770-773.
124. Mahadevia PS, Alexander JE, Rojas-Corona R, et al. Pseudosarcomatous stromal reaction in primary and metastatic urothelial carcinoma. A source of diagnostic difficulty. Am J Surg Pathol 1989;13:782-790.
125. Young RH. Spindle cell lesions of the urinary bladder. Histol Histopathol 1990;5:505-512.
126. Peyromaure M, Beuzeboc P, Chekulaev D, et al. Sarcomatoid carcinoma with heterologous osteoid differentiation. Prog Urol 2006;16:378-380.
127. Amir G, Rosenmann E. Osteoclast-like giant cell tumour of the urinary bladder. Histopathology 1990;17:413-418.
128. Garcia Garcia F, Garcia Ligero J, Martinez Diaz F, et al. Bladder carcinoma with osteoclast-type giant cells. A case with a rare presentation. Review of the literature. Actas Urol Esp 2003;27:317-320.
129. Kruger S, Johannisson R, Kausch I, et al. Papillary urothelial bladder carcinoma associated with osteoclast-like giant cells. Int Urol Nephrol 2005;37:61-64.
130. Zukerberg LR, Armin AR, Pisharodi L, et al. Transitional cell carcinoma of the urinary bladder with osteoclast-type giant cells: a report of two cases and review of the literature. Histopathology 1990;17: 407-411.
131. Baydar D, Amin MB, Epstein JI. Osteoclast-rich undifferentiated carcinomas of the urinary tract. Mod Pathol 2006;19:161-171.
132. O'Connor RC, Hollowell CM, Laven BA, et al. Recurrent giant cell carcinoma of the bladder. J Urol 2002;167:1784.
133. Oncology™ NCPGi. Bladder Cancer. 2007. 1 January 2009 cited. Available athttp://www.nccn.org/professionals/physician-gls/PDF/bladder.pdf.
134. Chuang AY, DeMarzo AM, Veltri RW, et al. Immuno-histochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Am J Surg Pathol 2007;31:1246-1255.
135. Kunju LP, Mehra R, Snyder M, et al. Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohisto-chemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma. Am J Clin Pathol 2006;125:675-681.